Firebrick Pharma Ltd (FRE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.543x

Based on the latest financial reports, Firebrick Pharma Ltd (FRE) has a cash flow conversion efficiency ratio of -0.543x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.05 Million ≈ $-745.48K USD) by net assets (AU$1.94 Million ≈ $1.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Firebrick Pharma Ltd to measure how many days the company can operate on defensive assets alone.

Firebrick Pharma Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Firebrick Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Firebrick Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Firebrick Pharma Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Patkol Public Company Limited BK:PK	-0.022x
Superior Resources Ltd AU:SPQ	-0.025x
Mcnally Bharat Engineering Company Limited NSE:MBECL	0.000x
Lombard et Medot SA PA:MLCAC	N/A
Agri-Tech (India) Limited NSE:AGRITECH	-0.010x
COMTEC SOLAR SYS HD -004 F:8C11	N/A
Canstar Resources Inc V:ROX	4.248x
Bon Natural Life Ltd NASDAQ:BON	0.076x

Annual Cash Flow Conversion Efficiency for Firebrick Pharma Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of Firebrick Pharma Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Firebrick Pharma Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.56 Million ≈ $1.10 Million	AU$-1.78 Million ≈ $-1.26 Million	-1.143x	-3.12%
2024-06-30	AU$2.12 Million ≈ $1.50 Million	AU$-2.34 Million ≈ $-1.66 Million	-1.109x	+52.54%
2023-06-30	AU$2.48 Million ≈ $1.75 Million	AU$-5.78 Million ≈ $-4.09 Million	-2.336x	-360.20%
2022-06-30	AU$8.28 Million ≈ $5.86 Million	AU$-4.20 Million ≈ $-2.97 Million	-0.508x	-202.88%
2021-06-30	AU$11.55 Million ≈ $8.17 Million	AU$-1.94 Million ≈ $-1.37 Million	-0.168x	+93.35%
2020-06-30	AU$390.60K ≈ $276.37K	AU$-985.01K ≈ $-696.96K	-2.522x	-155.58%
2019-06-30	AU$1.08 Million ≈ $763.34K	AU$-1.06 Million ≈ $-753.18K	-0.987x	--

About Firebrick Pharma Ltd

AU:FRE Australia Drug Manufacturers - General

Market Cap

$7.45 Million

AU$10.54 Million AUD

Market Cap Rank

#27717 Global

#1415 in Australia

Share Price

AU$0.04

Change (1 day)

-7.50%

52-Week Range

AU$0.04 - AU$0.08

All Time High

AU$0.65